Cargando…
Corrigendum to: “Novel and emerging mutations of SARS-CoV-2: Biomedical implications” [Biomed. Pharmacother. 139 (2021) 111599]
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Masson SAS.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123412/ https://www.ncbi.nlm.nih.gov/pubmed/34001417 http://dx.doi.org/10.1016/j.biopha.2021.111723 |
| _version_ | 1783692898649243648 |
|---|---|
| author | Mohammadi, Elmira Shafiee, Fatemeh Shahzamani, Kiana Ranjbar, Mohammad Mehdi Alibakhshi, Abbas Ahangarzadeh, Shahrzad Beikmohammadi, Leila Shariati, Laleh Hooshmandi, Soodeh Ataei, Behrooz HaghjooyJavanmard, Shaghayegh |
| author_facet | Mohammadi, Elmira Shafiee, Fatemeh Shahzamani, Kiana Ranjbar, Mohammad Mehdi Alibakhshi, Abbas Ahangarzadeh, Shahrzad Beikmohammadi, Leila Shariati, Laleh Hooshmandi, Soodeh Ataei, Behrooz HaghjooyJavanmard, Shaghayegh |
| author_sort | Mohammadi, Elmira |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8123412 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Published by Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81234122021-05-17 Corrigendum to: “Novel and emerging mutations of SARS-CoV-2: Biomedical implications” [Biomed. Pharmacother. 139 (2021) 111599] Mohammadi, Elmira Shafiee, Fatemeh Shahzamani, Kiana Ranjbar, Mohammad Mehdi Alibakhshi, Abbas Ahangarzadeh, Shahrzad Beikmohammadi, Leila Shariati, Laleh Hooshmandi, Soodeh Ataei, Behrooz HaghjooyJavanmard, Shaghayegh Biomed Pharmacother Corrigendum Published by Elsevier Masson SAS. 2021-08 2021-05-15 /pmc/articles/PMC8123412/ /pubmed/34001417 http://dx.doi.org/10.1016/j.biopha.2021.111723 Text en © 2021 Published by Elsevier Masson SAS. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Corrigendum Mohammadi, Elmira Shafiee, Fatemeh Shahzamani, Kiana Ranjbar, Mohammad Mehdi Alibakhshi, Abbas Ahangarzadeh, Shahrzad Beikmohammadi, Leila Shariati, Laleh Hooshmandi, Soodeh Ataei, Behrooz HaghjooyJavanmard, Shaghayegh Corrigendum to: “Novel and emerging mutations of SARS-CoV-2: Biomedical implications” [Biomed. Pharmacother. 139 (2021) 111599] |
| title | Corrigendum to: “Novel and emerging mutations of SARS-CoV-2: Biomedical implications” [Biomed. Pharmacother. 139 (2021) 111599] |
| title_full | Corrigendum to: “Novel and emerging mutations of SARS-CoV-2: Biomedical implications” [Biomed. Pharmacother. 139 (2021) 111599] |
| title_fullStr | Corrigendum to: “Novel and emerging mutations of SARS-CoV-2: Biomedical implications” [Biomed. Pharmacother. 139 (2021) 111599] |
| title_full_unstemmed | Corrigendum to: “Novel and emerging mutations of SARS-CoV-2: Biomedical implications” [Biomed. Pharmacother. 139 (2021) 111599] |
| title_short | Corrigendum to: “Novel and emerging mutations of SARS-CoV-2: Biomedical implications” [Biomed. Pharmacother. 139 (2021) 111599] |
| title_sort | corrigendum to: “novel and emerging mutations of sars-cov-2: biomedical implications” [biomed. pharmacother. 139 (2021) 111599] |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123412/ https://www.ncbi.nlm.nih.gov/pubmed/34001417 http://dx.doi.org/10.1016/j.biopha.2021.111723 |
| work_keys_str_mv | AT mohammadielmira corrigendumtonovelandemergingmutationsofsarscov2biomedicalimplicationsbiomedpharmacother1392021111599 AT shafieefatemeh corrigendumtonovelandemergingmutationsofsarscov2biomedicalimplicationsbiomedpharmacother1392021111599 AT shahzamanikiana corrigendumtonovelandemergingmutationsofsarscov2biomedicalimplicationsbiomedpharmacother1392021111599 AT ranjbarmohammadmehdi corrigendumtonovelandemergingmutationsofsarscov2biomedicalimplicationsbiomedpharmacother1392021111599 AT alibakhshiabbas corrigendumtonovelandemergingmutationsofsarscov2biomedicalimplicationsbiomedpharmacother1392021111599 AT ahangarzadehshahrzad corrigendumtonovelandemergingmutationsofsarscov2biomedicalimplicationsbiomedpharmacother1392021111599 AT beikmohammadileila corrigendumtonovelandemergingmutationsofsarscov2biomedicalimplicationsbiomedpharmacother1392021111599 AT shariatilaleh corrigendumtonovelandemergingmutationsofsarscov2biomedicalimplicationsbiomedpharmacother1392021111599 AT hooshmandisoodeh corrigendumtonovelandemergingmutationsofsarscov2biomedicalimplicationsbiomedpharmacother1392021111599 AT ataeibehrooz corrigendumtonovelandemergingmutationsofsarscov2biomedicalimplicationsbiomedpharmacother1392021111599 AT haghjooyjavanmardshaghayegh corrigendumtonovelandemergingmutationsofsarscov2biomedicalimplicationsbiomedpharmacother1392021111599 |